Neuromuscular Research · Clinical Trial Update Hawaii ALS & Neuromuscular Center Selected to Investigate Povetacicept in Generalized Myasthenia Gravis A milestone for Hawaii patients, caregivers, and the neuromuscular research community The Hawaii ALS & Neuromuscular Center team — bringing world-class…
The Hawaii ALS and Neuromuscular Center has been selected to participate in the ADAPT-EARLY clinical trial, a Phase 4 research study evaluating efgartigimod PH20 SC in adults with new-onset generalized myasthenia gravis (gMG). This important study focuses on early treatment…
